Skip to main content

Company name

Mega Pharma Holding Uruguay S.A.

Project number

16522-01

Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.

E&S category
tooltip

B

Country

Regional

Sector

Social Infrastructure

Status

Proposed

Disclosed date

11/13/2026

Projected date at which a project will be put forward for the Board of Executive Directors’ approval.

Projected board date
tooltip

12/15/2026

Approval date

N/A

Signed date

N/A

Sponsoring entity

N/A

Investment Operations Department Contact

Corporates Division

Investment type

Syndicated amount

N/A

Financing amount

USD $ 90,000,000

Currency

USD

Project scope and objective

The proposed transaction consists of a senior secured financing facility of up to US$90 million for the Megalabs Group, specifically for some of its main subsidiaries in the region. The financing includes a loan consisting of: (i) a committed tranche from IDB Invest of up to US$20 million to finance the company’s planned investments in Venezuela for 2026 and 2027, associated with the expansion of production capacity serving that country; (ii) an additional uncommitted tranche of up to US$70 million to support future investments to be made at its Parque de las Ciencias plant as well as at the Laboratorios Poen Argentina export plant. In both cases, the funds are also intended to increase production capacity.


Megalabs is a conglomerate of companies in the pharmaceutical sector specializing in the production and distribution of a wide range of medications. Megalabs has a diversified product portfolio and operates in both the manufacturing and distribution segments across 18 countries in Latin America and the Caribbean. Megalabs employs more than 9,000 people in the region.

For information requests about the project.

Request information

Learn more about how we provide private-sector solutions in the region .

Environmental and social review

IDB Invest conducts an environmental and social due diligence (ESDD) commensurate with the nature, scale, and stage of the project, and with its level of environmental and social risks and impacts. The ESDD will confirm the project E&S categorization and assess the project with respect to the client requirements in IDB Invest Environmental and Social Sustainability Policy. The results of the ESDD, including any identified gaps are described in the Environmental and Social Review Summary (ESRS) provided below. For projects approved as of 2016, any gaps with respect to IDB Invest's Environmental and Social Sustainability Policy at the time of the ESDD are addressed in the Environmental and Social Action Plan (ESAP) presented below, to comply with the date mentioned above.

MEGALABS - ENVIRONMENTAL AND SOCIAL REVIEW SUMMARY (RRAS OU ESRS)

297.0 Kb

MEGALABS - ENVIRONMENTAL AND SOCIAL ACTION PLAN (ESAP OR PAAS)

143.4 Kb

For information requests about the project.

Request information

Learn more about how we provide private-sector solutions in the region .

Contact information

For information requests about the project.

Request information

Alternatively, you may also use the following contact information :

Client Contact

PHONE NUMBER

+598 95852555

POST OFFICE ADDRESS

Postal Address: 14000

For information requests about the project.

Request information

Learn more about how we provide private-sector solutions in the region .